Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement in Low Energy Hip Fracture Patients?

NCT03182751 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03182751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03182751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement in Low Energy Hip Fracture Patients?
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
April 2, 2018
Completion date
May 24, 2022
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip fractures, intertrochanteric fractures